You are here

Heidi Klepin (US)

Dr Heidi Klepin, MD, MS is a dually trained geriatrician and oncologist with a clinical and research focus on geriatric oncology. Her primary research focuses on the following themes among older cancer patients: (1) patient-level characteristics as predictors of treatment outcomes; (2) the impact of chemotherapy on physical, cognitive and emotional health; and (3) interventions to minimize treatment-associated disability and improve quality of life. She has received external funding including an American Society of Hematology (ASH) ASP-ASH Junior Faculty Scholar Award, a Paul B. Beeson Patient-Oriented Research Career Development Award in Aging (K23), and the Gabrielle’s Angel Foundation for Cancer Research Integrative Medicine Award. She is actively involved in collaborative research through the Cancer and Aging Research Group and Alliance for Clinical Trials in Oncology. Her clinical effort includes a Geriatric Oncology Clinic focused on providing oncology care for adults ≥75 years of age.

November 16, 2018
4:15pm to 5:45pm With progress comes controversy: discussion on the dilution vs dispersion of geriatric assessment Room E 102 Tanya Wildes (US), Hans Wildiers (BE), Marije Hamaker (NL), Cindy Kenis (BE), Siri Rostoft (NO), Enrique Soto Perez de Celis (MX), Martine Puts (CA), Heidi Klepin (US)
November 18, 2018
9:00am to 10:00am Oral abstract session 1: Hematologic malignancies in the elderly and basic science Room E 102 Heidi Klepin (US), Nina Neuendorff (DE)
3:30pm to 4:45pm SIOG Guidelines update 2018 Forum room Martine Extermann (US), Tanya Wildes (US), Rupert Bartsch (AT), Heidi Klepin (US)